Result entries:  4630
DRACP ID Peptide Name Sequence Sequence Length Origin
DRACP02486 [Lys4, Lys5, Lys15, Lys16] XT-7 GLLKKLLKIAAKVGKKLL 18 Synthetic (Derived from XT-7)
DRACP02487 P6 (SEQ ID NO:1 for Patent US 20030186868 A1) RRPKGRGKRRREKQRP 16 Synthetic
DRACP02488 P6V8 (SEQ ID NO:4 for Patent US 20030186868 A1) RRPKGRGKRRREKQRPCDKPRR 22 Synthetic
DRACP02489 P6V8CS (SEQ ID NO:5 for Patent US 20030186868 A1) RRPKGRGKRRREKQRPSDKPRR 22 Synthetic
DRACP02490 P6P7 (SEQ ID NO:7 for Patent US 20030186868 A1) RRPKGRGKRRREKQRPDAVPRR 22 Synthetic
DRACP02491 P6V8-3NCS1-7CC (SEQ ID NO:12 for Patent US 20030186868 A1) CKGRGKRCREKQRPSDKPRR 20 Synthetic
DRACP02492 P6V8-3N (SEQ ID NO:13 for Patent US 20030186868 A1) KGRGKRRREKQRPCDKPRR 19 Synthetic
DRACP02493 P6V8-8N (SEQ ID NO:14 for Patent US 20030186868 A1) RRREKQRPCDKPRR 14 Synthetic
DRACP02494 P6V8-3NCS-1C (SEQ ID NO:17 for Patent US 20030186868 A1) KGRGKRRREKQRPSDKPR 18 Synthetic
DRACP02495 P6V8-3NCS-2C (SEQ ID NO:18 for Patent US 20030186868 A1) KGRGKRRREKQRPSDKP 17 Synthetic
DRACP02496 P6V8-3NCS (SEQ ID NO:20 for Patent US 20030186868 A1) KGRGKRRREKQRPSDKPRR 19 Synthetic
DRACP02497 AS-2 (SEQ ID NO:22 for Patent US 20030186868 A1) RRPKGRAAARREKQRPSDKPRR 22 Synthetic
DRACP02498 AS-3 (SEQ ID NO:23 for Patent US 20030186868 A1) RRPKGRGKRAAAKQRPSDKPRR 22 Synthetic
DRACP02499 P6V8-3NCSA1 (SEQ ID NO:24 for Patent US 20030186868 A1) AGRGKRRREKQRPSDKPRR 19 Synthetic
DRACP02500 P6V8-3NCSA5 (SEQ ID NO:25 for Patent US 20030186868 A1) KGRGARRREKQRPSDKPRR 19 Synthetic
DRACP02501 P6V8-3NCSA3 (SEQ ID NO:27 for Patent US 20030186868 A1) KGAGKRRREKQRPSDKPRR 19 Synthetic
DRACP02502 P6V8-3NCSA6 (SEQ ID NO:28 for Patent US 20030186868 A1) KGRGKARREKQRPSDKPRR 19 Synthetic
DRACP02503 P6V8-3NRGCS (SEQ ID NO:31 for Patent US 20030186868 A1) KGRGKRRREKQGPSDKPRR 19 Synthetic
DRACP02504 P6V8-3NCSA16,18,19 (SEQ ID NO:32 for Patent US 20030186868 A1) KGRGKRRREKQRPSDAPAA 19 Synthetic
DRACP02505 P6V8-3NCSA7,8,10 (SEQ ID NO:33 for Patent US 20030186868 A1) KGRGKRAAEAQRPSDKPRR 19 Synthetic
DRACP02506 P6V8-3NCSA7,8,12 (SEQ ID NO:34 for Patent US 20030186868 A1) KGRGKRAAEKQAPSDKPRR 19 Synthetic
DRACP02507 P6V8-3NCSA1,5,7,8,10 (SEQ ID NO:35 for Patent US 20030186868 A1) AGRGARAAEAQRPSDKPRR 19 Synthetic
DRACP02508 AS-5 (SEQ ID NO:39 for Patent US 20030186868 A1) RRPKGRGKRRREKQRPSDAAAR 22 Synthetic
DRACP02509 Chemokinostatin-1 NGRKACLNPASPIVKKIIEKMLNS 24 Homo sapiens (CXCL1/Gro-α)
DRACP02510 Chemokinostatin-3 NGKKACLNPASPMVQKIIEKIL 22 Homo sapiens (CXCL3/Gro-γ)
DRACP02511 Chemokinostatin-5 NGKEICLDPEAPFLKKVIQKILD 23 Homo sapiens (CXCL5/ENA-78)
DRACP02512 Chemokinostatin-6 NGKQVCLDPEAPFLKKVIQKILDS 24 Homo sapiens (CXCL6/GCP-2)
DRACP02513 Chemokinostatin-7 DGRKICLDPDAPRIKKIVQKKL 22 Homo sapiens (CXCL7/PBP)
DRACP02514 Chemokinostatin-8 DGRELCLDPKENWVQRVVEKFLK 23 Homo sapiens (CXCL8/IL-8)
DRACP02515 N17 KILRGVSKKIMRTFLRR 17 Synthetic
<< < 81 82 83 84 85 >>

DRACP is developed by Dr.Zheng's team.